Mischa Koenen (Netherlands)
UMC Utrecht Center of Translational ImmunologyPresenter of 1 Presentation
PREMATURE BIRTH IS ASSOCIATED WITH PRIMARY ANTIBODY DEFICIENCY IN YOUNG CHILDREN WITH RECURRENT RESPIRATORY TRACT INFECTIONS (ID 790)
Abstract
Background
Recurrent respiratory tract infections (rRTI) affect around 10-15% of children aged 0-5 years. Some children with rRTI suffer from an underlying immunological defect, such as a primary antibody deficiency (PAD). We investigated the prevalence of and epidemiological risk factors associated with PAD in children with rRTI and linked this to disease severity.
Methods
Children <7 years of age with rRTI undergoing immunological screening in a secondary and tertiary hospital in The Netherlands were included in a prospective cohort study. In a subgroup of children, parent-reported RTI symptoms were monitored during the winter season with a daily diary mobile phone application. Patient characteristics associated with PAD were identified using multivariable logistic regression analysis with model selection.
Results
Between 2016 and 2019 we included 147 children with rRTI with a median age of 3.4 years (interquartile range 2.1-5.2 years). Although major immune deficiencies were rarely observed, a high percentage of children (55%) showed mild antibody deficiencies. Most prevalent were complete/partial IgA deficiency (23%), IgG4-subclass deficiency (12%) and combined IgA and total IgG deficiency (9%). Prematurity was significantly associated with PAD in multivariate analysis (see Table). In 80 children daily RTI symptoms were monitored during a winter season; the prevalence and duration of RTI symptoms did not differ significantly between children with and without PAD.
Conclusions
The prevalence of PAD in a Dutch cohort of young children with rRTI was remarkably high compared to older pediatric cohorts. Prematurity was associated with PAD, underlining that immune maturation lies at the basis of mild PAD commonly found in the first years of life. Interestingly, RTI symptoms did not differ between children with and without PAD, which suggests that more factors than PAD alone contribute to disease severity.
Clinical Trial Registration
Not applicable